Brain tumor removal in Republic of Korea typically costs from AUD $21,664 to AUD $51,206. Prices depend on the surgical approach, tumor complexity, and the specific hospital tier. In Australia, the average cost for this procedure is AUD $67,525. By travelling to Seoul, Australians can save approximately 46%. Costs generally include neurosurgeon fees, anaesthesia, and a hospital stay of 5 to 14 days.
Bookimed Expert Insight: Choosing a digitalised facility in Seoul offers distinct value for complex neurosurgery. Leading centres like Seoul National University Hospital use BESTcare systems to mitigate medical errors. For those seeking efficiency, Asan Medical Center performs over 65,000 operations annually with high success rates. Samsung Medical Center provides presidential-standard care, often integrating Novalis and IGRT technologies for precise tumor targeting.
| Republic of Korea | Thailand | Turkey | |
| Brain tumor removal | from AUD $21,664 | from AUD $42,203 | from AUD $5,908 |
Dr. Han Yeongmin is a neurosurgeon (MD, PhD). He is Medical Director and Director of the Neurosurgery Center at Incheon St. Mary’s Hospital. He treats cerebrovascular disease and peripheral nerve disorders. He also specializes in brain tumors and skull base surgery. Conditions include stroke, cerebral hemorrhage, cerebral infarction, and moyamoya disease. He performs PEN, PNP, and SNB. He also offers microscopic and endoscopic discectomy, artificial disc replacement, MIS-TLIF/minimally invasive spinal fusion, and vertebroplasty.
He earned his MD and PhD from The Catholic University of Korea. He served as a visiting professor in cerebrovascular and skull base surgery at Barrow Neurological Institute (Phoenix, Arizona, USA). He also served at Harborview Medical Center, University of Washington (Seattle, USA).
His publications include co-authorship of Chapter 52 of the Textbook of Korean Cerebrovascular Surgery. He also co-authored Acoustic Neuroma Oncology. He is a full member of KNS, KSCVS, KSBS, KBTS, KNTS, KSNS, and KSPNS.
Dr. Yang Se Yeon is a neurosurgeon and Head of the Department of Neurosurgery at Naeun Hospital. He specializes in cerebral infarction, cerebral hemorrhage, cerebral aneurysm, moyamoya disease, carotid artery stenosis, vascular dizziness, and head trauma.
He graduated from The Catholic University of Korea College of Medicine. He also earned a Master’s in Medicine there. He completed an internship and a neurosurgery residency at Catholic Medical Center. He then completed a clinical fellowship and served as a clinical assistant professor at Uijeongbu St. Mary’s Hospital.
He has served as a staff neurosurgeon at the Northern Gyeonggi Regional Trauma Center. He was also Head of Neurosurgery at G-SAM Hospital.
Neurosurgeon, specializing in spinal neurosurgery
35 years old
South Korea houses premier neurosurgery centres such as Seoul National University Hospital and Samsung Medical Center. These perform thousands of brain tumour removals annually. The facilities specialise in Gamma Knife radiosurgery and robotic-assisted resections. They offer successful outcomes for complex malignant and skull-base tumours in Seoul.
Bookimed Expert Insight: While Asan Medical Center is Korea's largest hospital, Seoul National University Hospital reports a 90% success rate specifically for Gamma Knife procedures. Patients seeking non-invasive options should prioritise centres with dedicated Gamma Knife units. They should look for units that handle over 700 cases annually, as this indicates maximum specialist experience.
Patient Consensus: Patients value the well-established international programs at the Gangnam branches and the 24/7 interpreter services in Seoul. Many recommend consulting multiple neurosurgeons to compare treatment plans. They also advise securing detailed cost estimates before travelling to the Republic of Korea.
South Korean neurosurgeons use techniques like Gamma Knife radiosurgery, robotic-assisted surgery, and fluorescence-guided microsurgery to remove tumours. Facilities like Seoul National University Hospital achieve 90% success rates for non-invasive treatments, while major centres like Samsung Medical Center use Novalis Tx and Da Vinci systems for precision.
Bookimed Expert Insight: Patients told surgery is impossible elsewhere should enquire about Korean navigation protocols. Seoul National University Hospital performs 3,800 neurosurgical interventions yearly. Their high volume allows them to use emerging techniques. One such technique is post-operative phototherapy, which clears residual cells. This level of specialisation helps these centres manage complex tumours typically considered inoperable.
Patient Consensus: Surgeons in South Korea often combine standard craniotomy with imaging like intraoperative MRI. People appreciate that major hospitals in Seoul provide personal coordinators and interpreters to assist during appointments.
Medical packages for brain tumour removal in South Korea provide a comprehensive surgical pathway. This includes pre-op diagnostics, specialist neurosurgeon fees, and hospital stays. Standard inclusions feature imaging like MRI or CT scans, anaesthesia, and inpatient recovery. These are provided at JCI-accredited Seoul facilities such as Asan Medical Centre.
Bookimed Expert Insight: While base surgical costs start from A$21,300, South Korea stands out for zero-wait consultation. Major hospitals in Seoul allow patients to complete diagnostics and specialist meetings within 48 hours. This efficiency often reduces total travel time compared to other international destinations.
Patient Consensus: Patients find the transparent pricing and lack of referral delays refreshing. They recommend securing all pathology reports and digital imaging before departing. This helps with follow-up care in Australia.
Patients should expect a 2–4 day diagnostic phase. This phase involves high-resolution MRI and PET-CT scans to map tumour boundaries. Multidisciplinary teams at JCI-accredited Seoul centres then finalise surgical plans. They often use Gamma Knife or Da Vinci robotic systems for precision.
Bookimed Expert Insight: Many facilities suggest a 3-day inpatient stay. However, modern Seoul hospitals increasingly offer outpatient diagnostics for stable cases. Patients can save on costs by choosing facilities with GHA accreditation. This accreditation specifically streamlines pre-surgical logistics for international visitors.
Patient Consensus: Patients can expect treatment protocols identical to Australian or US standards. Recovery takes place in affordable private rooms. Patients suggest confirming insurance coverage for biopsies early. This helps manage out-of-pocket expenses in South Korea.